Literature DB >> 21530869

The CHI3L1 rs4950928 polymorphism is associated with asthma-related hospital admissions in children and young adults.

Jason Cunningham1, Kaninika Basu, Roger Tavendale, Colin N A Palmer, Helen Smith, Somnath Mukhopadhyay.   

Abstract

BACKGROUND: Asthma exacerbations are the commonest cause of medical admissions in childhood. These have a significant effect on quality of life and are a major financial burden on worldwide healthcare services. A range of gene-environment interactions may influence the course and severity of asthma in children and their response to medication. The Chitinase 3-like 1 (CHI3L1)-131C>G genotype (rs4950928) is associated with increased asthma susceptibility and severity in adults.
OBJECTIVES: To study the interactions of the Chitinase 3-Like-1 functional promoter SNP rs4950928 and its role on asthma exacerbations in a population of children and young adults with asthma.
METHODS: A cross-sectional survey was undertaken using medical records and direct interviews of 1,071 children and young adults with asthma, aged 3 to 22 years, from Scotland. Saliva samples were collected for genotyping. Binary logistic regression was used to calculate odds ratios (ORs) and P-values for measures of asthma exacerbations.
RESULTS: The minor -131G allele confers protection against asthma-related hospital admissions (OR = 0.62; 95% CI 0.41-0.92; P = .018) in children and young adults with asthma.
CONCLUSIONS: Our study shows that rs4950928 is significantly associated with hospital admissions in children and young adults; screening for rs4950928 may predict asthma-related hospital admissions, and through individually defined treatment management plans, potentially reduce health care costs.
Copyright © 2011 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21530869     DOI: 10.1016/j.anai.2011.01.030

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


  11 in total

Review 1.  Association between YKL-40 and asthma: a systematic meta-analysis.

Authors:  Yihan Jin; Jie Song; Fang Xu; Di Zhang; Jinfang He; Jiakun Zheng; Yanan Zhang; Jintong Li; Yikun Guo; Mengjiao Xu; Xiangfeng Yu; Yanbin Liu; Qinghua Liu; Jun Yan
Journal:  Sleep Breath       Date:  2021-10-16       Impact factor: 2.655

2.  Noninvasive analysis of the sputum transcriptome discriminates clinical phenotypes of asthma.

Authors:  Xiting Yan; Jen-Hwa Chu; Jose Gomez; Maria Koenigs; Carole Holm; Xiaoxuan He; Mario F Perez; Hongyu Zhao; Shrikant Mane; Fernando D Martinez; Carole Ober; Dan L Nicolae; Kathleen C Barnes; Stephanie J London; Frank Gilliland; Scott T Weiss; Benjamin A Raby; Lauren Cohn; Geoffrey L Chupp
Journal:  Am J Respir Crit Care Med       Date:  2015-05-15       Impact factor: 21.405

3.  Protective role of IL-6 in vascular remodeling in Schistosoma pulmonary hypertension.

Authors:  Brian B Graham; Jacob Chabon; Rahul Kumar; Ewa Kolosionek; Liya Gebreab; Elias Debella; Michael Edwards; Katrina Diener; Ted Shade; Gao Bifeng; Angela Bandeira; Ghazwan Butrous; Kenneth Jones; Mark Geraci; Rubin M Tuder
Journal:  Am J Respir Cell Mol Biol       Date:  2013-12       Impact factor: 6.914

4.  CTNNA3 and SEMA3D: Promising loci for asthma exacerbation identified through multiple genome-wide association studies.

Authors:  Michael J McGeachie; Ann C Wu; Sze Man Tse; George L Clemmer; Joanne Sordillo; Blanca E Himes; Jessica Lasky-Su; Robert P Chase; Fernando D Martinez; Peter Weeke; Christian M Shaffer; Hua Xu; Josh C Denny; Dan M Roden; Reynold A Panettieri; Benjamin A Raby; Scott T Weiss; Kelan G Tantisira
Journal:  J Allergy Clin Immunol       Date:  2015-06-12       Impact factor: 10.793

5.  An Interleukin 13 Polymorphism Is Associated with Symptom Severity in Adult Subjects with Ever Asthma.

Authors:  Simone Accordini; Lucia Calciano; Cristina Bombieri; Giovanni Malerba; Francesca Belpinati; Anna Rita Lo Presti; Alessandro Baldan; Marcello Ferrari; Luigi Perbellini; Roberto de Marco
Journal:  PLoS One       Date:  2016-03-17       Impact factor: 3.240

6.  Transcriptomic analysis comparing mouse strains with extreme total lung capacities identifies novel candidate genes for pulmonary function.

Authors:  Leema George; Ankita Mitra; Tania A Thimraj; Martin Irmler; Sangeetha Vishweswaraiah; Lars Lunding; Dorothea Hühn; Alicia Madurga; Johannes Beckers; Heinz Fehrenbach; Swapna Upadhyay; Holger Schulz; George D Leikauf; Koustav Ganguly
Journal:  Respir Res       Date:  2017-08-09

Review 7.  Genetic Signatures of Asthma Exacerbation.

Authors:  Heung Woo Park; Kelan G Tantisira
Journal:  Allergy Asthma Immunol Res       Date:  2017-05       Impact factor: 5.764

Review 8.  Acute Severe Asthma in Adolescent and Adult Patients: Current Perspectives on Assessment and Management.

Authors:  Eirini Kostakou; Evangelos Kaniaris; Effrosyni Filiou; Ioannis Vasileiadis; Paraskevi Katsaounou; Eleni Tzortzaki; Nikolaos Koulouris; Antonia Koutsoukou; Nikoletta Rovina
Journal:  J Clin Med       Date:  2019-08-22       Impact factor: 4.241

9.  Personalized management of asthma exacerbations: lessons from genetic studies.

Authors:  Alberta L Wang; Kelan G Tantisira
Journal:  Expert Rev Precis Med Drug Dev       Date:  2016-12-20

10.  YKL-40 and genetic status of CHI3L1 in a large group of asthmatics.

Authors:  Jakob W Hansen; Simon F Thomsen; Celeste Porsbjerg; Linda M Rasmussen; Lotte Harmsen; Julia S Johansen; Vibeke Backer
Journal:  Eur Clin Respir J       Date:  2015-09-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.